Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics Price to Book Value : 9.523 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 9.523 |
| September 24, 2026 | 9.751 |
| September 23, 2026 | 9.751 |
| September 22, 2026 | 9.797 |
| September 21, 2026 | 9.751 |
| September 18, 2026 | 9.296 |
| September 17, 2026 | 9.751 |
| September 16, 2026 | 9.25 |
| September 15, 2026 | 9.318 |
| September 14, 2026 | 9.204 |
| September 11, 2026 | 9.159 |
| September 10, 2026 | 9.068 |
| September 09, 2026 | 9.478 |
| September 08, 2026 | 9.204 |
| September 04, 2026 | 9.113 |
| September 03, 2026 | 9.068 |
| September 02, 2026 | 9.296 |
| September 01, 2026 | 9.022 |
| August 31, 2026 | 9.159 |
| August 28, 2026 | 9.387 |
| August 27, 2026 | 9.614 |
| August 26, 2026 | 9.523 |
| August 25, 2026 | 9.068 |
| August 24, 2026 | 8.521 |
| August 21, 2026 | 9.432 |
| Date | Value |
|---|---|
| August 20, 2026 | 9.751 |
| August 19, 2026 | 9.842 |
| August 18, 2026 | 9.523 |
| August 17, 2026 | 9.569 |
| August 14, 2026 | 11.85 |
| August 13, 2026 | 11.39 |
| August 12, 2026 | 10.16 |
| August 11, 2026 | 10.02 |
| August 10, 2026 | 9.660 |
| August 07, 2026 | 10.30 |
| August 06, 2026 | 10.12 |
| August 05, 2026 | 10.21 |
| August 04, 2026 | 10.16 |
| August 03, 2026 | 9.979 |
| July 31, 2026 | 10.53 |
| July 30, 2026 | 9.797 |
| July 29, 2026 | 9.068 |
| July 28, 2026 | 9.068 |
| July 27, 2026 | 8.931 |
| July 24, 2026 | 9.341 |
| July 23, 2026 | 9.614 |
| July 22, 2026 | 10.21 |
| July 21, 2026 | 10.57 |
| July 20, 2026 | 10.30 |
| July 17, 2026 | 10.39 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.45 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8816 |
| Fulcrum Therapeutics, Inc. | 0.9183 |
Price to Book Value Related Metrics
| Price | 2.09 |
| Earnings Yield | -6.90% |
| Market Cap | 104.18M |